fotemustine has been researched along with Leukocytopenia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| A'Hern, R; Atkinson, H; Chang, J; Gore, ME; Lorentzos, A | 1 |
| Falkson, CI; Falkson, G; Falkson, HC | 1 |
| Boaziz, C; Coste, M; Haon, C; Raymond, E | 1 |
| Breitbart, E; Makki, A; Mohr, P; Schadendorf, D | 1 |
| Avril, MF; Bonneterre, J; Cupissol, D; Fargeot, P; Fumoleau, P; Grob, JJ; Israel, L; Kalis, B; Kerbrat, P; Lambert, D | 1 |
| Binder, M; Dorffner, R; Glebowski, E; Pehamberger, H; Winkler, A; Wolff, K | 1 |
| Crowther, D; Kerbrat, P; Lentz, MA; Mouridsen, HT; Santoro, A; Somers, R; Steward, WP; Tursz, T; van Glabbeke, M; Verweij, J | 1 |
| Cour, V; Fety, R; Lucas, C; Solere, P; Vignoud, J | 1 |
1 review(s) available for fotemustine and Leukocytopenia
| Article | Year |
|---|---|
Logistic regression model of fotemustine toxicity combining independent phase II studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anemia; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Female; Humans; Leukopenia; Logistic Models; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia | 1996 |
4 trial(s) available for fotemustine and Leukocytopenia
| Article | Year |
|---|---|
A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia; Treatment Outcome | 1994 |
Phase II trial of fotemustine in patients with metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia; Treatment Failure | 1994 |
Combined treatment of stage IV melanoma patients with amifostine and fotemustine--a pilot study.
Topics: Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Drug Administration Schedule; Humans; Leukopenia; Melanoma; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Skin Neoplasms; Thrombocytopenia | 1998 |
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia | 1992 |
3 other study(ies) available for fotemustine and Leukocytopenia
| Article | Year |
|---|---|
Fotemustine plus dacarbazine for malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Thrombocytopenia | 1992 |
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Thrombocytopenia | 1992 |
Hepatic intra-arterial infusion of fotemustine: pharmacokinetics.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia | 1992 |